Literature DB >> 24966591

Association between metabolic factors and chronic hepatitis B virus infection.

Chien-Hsieh Chiang1, Kuo-Chin Huang1.   

Abstract

There are limited data regarding the relationship between chronic hepatitis B virus (HBV) infection and metabolic factors. This article aims to highlight the link of metabolic factors with hepatitis B surface antigen (HBsAg) serostatus, HBV load, and HBV-related hepatocellular carcinoma (HCC). Although HBsAg-positive serostatus was positively correlated with a high risk of metabolic syndrome in students, chronic HBV-infected individuals have high serum adiponectin levels. The androgen pathway in HBV carriers with a low body mass index is more triggered which leads to enhanced HBV replication. High HBV load was inversely associated with obesity in hepatitis B e antigen (HBeAg)-seropositive HBV carriers; while in HBeAg-seronegative HBV carriers, high HBV load was inversely related to hypertriglyceridemia rather than obesity. For overweight and obese HBV-infected patients, high HBV load was positively associated with serum adiponectin levels. Several large cohort studies have revealed a positive link of diabetes with incidence of HBV-related HCC. However, the association between incidence of HCC and metabolic factors other than diabetes is still inconclusive. More long-term prospective studies should elucidate the association of chronic HBV infection and its outcomes with metabolic factors in clinical practice.

Entities:  

Keywords:  Adiponectin; Diabetes; Hepatitis B surface antigen; Hepatitis B viral load; Hepatocellular carcinoma; Obesity

Mesh:

Substances:

Year:  2014        PMID: 24966591      PMCID: PMC4064066          DOI: 10.3748/wjg.v20.i23.7213

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

1.  Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection.

Authors:  Yu-Tse Tsan; Chang-Hsing Lee; Jung-Der Wang; Pau-Chung Chen
Journal:  J Clin Oncol       Date:  2012-01-23       Impact factor: 44.544

2.  Adiponectin, a downstream target gene of peroxisome proliferator-activated receptor γ, controls hepatitis B virus replication.

Authors:  Sarah Yoon; Jaesung Jung; Taeyeung Kim; Sun Park; Yong-Joon Chwae; Ho-Joon Shin; Kyongmin Kim
Journal:  Virology       Date:  2010-11-06       Impact factor: 3.616

3.  The metabolic activator FOXO1 binds hepatitis B virus DNA and activates its transcription.

Authors:  Amir Shlomai; Yosef Shaul
Journal:  Biochem Biophys Res Commun       Date:  2009-02-20       Impact factor: 3.575

4.  Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study.

Authors:  J A Davila; R O Morgan; Y Shaib; K A McGlynn; H B El-Serag
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

5.  Hepatocellular carcinoma risk prediction model for the general population: the predictive power of transaminases.

Authors:  Chi-Pang Wen; Jie Lin; Yi Chen Yang; Min Kuang Tsai; Chwen Keng Tsao; Carol Etzel; Maosheng Huang; Chung Yi Hsu; Yuanqing Ye; Lopa Mishra; Ernest Hawk; Xifeng Wu
Journal:  J Natl Cancer Inst       Date:  2012-10-17       Impact factor: 13.506

6.  Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis.

Authors:  Chia-Chi Wang; Ching-Sheng Hsu; Chun-Jen Liu; Jia-Horng Kao; Ding-Shinn Chen
Journal:  J Gastroenterol Hepatol       Date:  2007-11-19       Impact factor: 4.029

7.  Serum adiponectin levels are associated with hepatitis B viral load in overweight to obese hepatitis B virus carriers.

Authors:  Chien-Hsieh Chiang; Jin-Shin Lai; Shou-Hung Hung; Long-Teng Lee; Jin-Chuan Sheu; Kuo-Chin Huang
Journal:  Obesity (Silver Spring)       Date:  2013-02       Impact factor: 5.002

8.  The hepatitis B virus X protein inhibits secretion of apolipoprotein B by enhancing the expression of N-acetylglucosaminyltransferase III.

Authors:  Sung-Koo Kang; Tae-Wook Chung; Ji-Young Lee; Young-Choon Lee; Richard E Morton; Cheorl-Ho Kim
Journal:  J Biol Chem       Date:  2004-04-29       Impact factor: 5.157

9.  Metabolic factors and subsequent risk of hepatocellular carcinoma by hepatitis virus infection status: a large-scale population-based cohort study of Japanese men and women (JPHC Study Cohort II).

Authors:  Manami Inoue; Norie Kurahashi; Motoki Iwasaki; Yasuhito Tanaka; Masashi Mizokami; Mitsuhiko Noda; Shoichiro Tsugane
Journal:  Cancer Causes Control       Date:  2008-12-30       Impact factor: 2.506

10.  Fifteen-year population attributable fractions and causal pies of risk factors for newly developed hepatocellular carcinomas in 11,801 men in Taiwan.

Authors:  Shu-Fen Liao; Hwai-I Yang; Mei-Hsuan Lee; Chien-Jen Chen; Wen-Chung Lee
Journal:  PLoS One       Date:  2012-04-10       Impact factor: 3.240

View more
  12 in total

Review 1.  Association between hepatitis B and metabolic syndrome: Current state of the art.

Authors:  Peter Jarcuska; Sylvia Drazilova; Jan Fedacko; Daniel Pella; Martin Janicko
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

2.  Relationship Between Metabolic Syndrome, Alanine Aminotransferase Levels, and Liver Disease Severity in a Multiethnic North American Cohort With Chronic Hepatitis B.

Authors:  Mandana Khalili; Margaret C Shuhart; Manuel Lombardero; Jordan J Feld; David E Kleiner; Raymond T Chung; Norah A Terrault; Mauricio Lisker-Melman; Arun Sanyal; Anna S Lok
Journal:  Diabetes Care       Date:  2018-03-29       Impact factor: 19.112

3.  Risk factors associated with liver steatosis and fibrosis in chronic hepatitis B patient with component of metabolic syndrome.

Authors:  Shaohang Cai; Zejin Ou; Duan Liu; Lili Liu; Ying Liu; Xiaolu Wu; Tao Yu; Jie Peng
Journal:  United European Gastroenterol J       Date:  2018-01-16       Impact factor: 4.623

4.  The Prevalence and Components of Metabolic Syndrome in Men from Infertile Couples and Its Relation on Semen Analysis.

Authors:  Minh Tam Le; Nhu Quynh Thi Tran; Nguyen Dac Nguyen; Quoc Huy Vu Nguyen
Journal:  Diabetes Metab Syndr Obes       Date:  2021-03-29       Impact factor: 3.168

5.  P2X7 Activation Enhances Lipid Accumulation During Adipocytes Differentiation Through Suppressing the Expression of Sirtuin-3, Sirtuin-5, and Browning Genes.

Authors:  Chien-Hsieh Chiang; Ching-Yuan Cheng; Yi-Ting Lien; Kuo-Chin Huang; Wan-Wan Lin
Journal:  Front Pharmacol       Date:  2022-04-06       Impact factor: 5.988

6.  Serum HBV surface antigen positivity is associated with low prevalence of metabolic syndrome: A meta-analysis.

Authors:  Yuanyuan Li; Ying Zhao; Jianping Wu
Journal:  PLoS One       Date:  2017-05-15       Impact factor: 3.240

7.  Peroxisome Proliferators Activated Receptor (PPAR) agonists activate hepatitis B virus replication in vivo.

Authors:  Lingyao Du; Yuanji Ma; Miao Liu; Libo Yan; Hong Tang
Journal:  Virol J       Date:  2017-05-25       Impact factor: 4.099

Review 8.  Immunometabolism: A novel perspective of liver cancer microenvironment and its influence on tumor progression.

Authors:  Qi Zhang; Yu Lou; Xue-Li Bai; Ting-Bo Liang
Journal:  World J Gastroenterol       Date:  2018-08-21       Impact factor: 5.742

9.  The Relationship of Diabetes and Smoking Status to Hepatocellular Carcinoma Mortality.

Authors:  Chien-Hsieh Chiang; Chia-Wen Lu; Hsieh-Cheng Han; Shou-Hung Hung; Yi-Hsuan Lee; Kuen-Cheh Yang; Kuo-Chin Huang
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.817

10.  Unawareness of Hepatitis B Virus Infection confers on Higher Rate of Metabolic Syndrome: A Community-based Study.

Authors:  Cheng-Hung Chien; Li-Wei Chen; Chih-Lang Lin; Su-Wie Chang; Yu-Chiau Shyu; Kuan-Fu Chen; Shuo-Wei Chen; Ching-Chih Hu; Chia-Ying Yu; Rong-Nan Chien
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.